Fineotex Chemical Limited

NSE:FCL.NS

366.5 (INR) • At close September 6, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 5,689.7045,169.9563,667.2532,171.7811,948.0221,809.4491,400.3651,280.6761,087.331,019.805866.708958.51798.06282.439207.471252.722296.36910.058
Cost of Revenue 3,759.9723,392.2552,364.9961,414.0481,238.8971,182.72860.272769.656636.569682.301616.159693.215594.834199.574143.347189.478228.55810.041
Gross Profit 1,929.7321,777.7011,302.257757.733709.125626.729540.093511.021450.76337.504250.549265.296203.22582.86564.12463.24567.8110.017
Gross Profit Ratio 0.3390.3440.3550.3490.3640.3460.3860.3990.4150.3310.2890.2770.2550.2930.3090.250.2290.002
Reseach & Development Expenses 15.0916.0474.44218.500000000000000
General & Administrative Expenses 039.66156.11266.47975.87722.027.60632.50535.888027.28747.38293.28813.29610.1228.424.2440.022
Selling & Marketing Expenses 084.868137.91558.4837.77224.54630.62137.29324.772021.10727.669000000
SG&A 506.12124.529194.027124.959113.64946.56638.22769.79860.6644.42792.079130.22493.28813.29610.1228.424.2440.022
Other Expenses 165.37573.0444.25715.4064.2463.8442.4120.780.52177.535160.439173.87715.8636.0690.2320.4450.331-0.046
Operating Expenses 506.12694.555610.078360.152372.954292.262235.997204.096185.728177.535160.439173.877109.15119.36410.35412.6367.183-0.024
Operating Income 1,423.6121,088.371693.868409.299336.17334.468304.096331.519288.581201.978111.641111.33894.07563.50153.7750.60860.6280.041
Operating Income Ratio 0.250.2110.1890.1880.1730.1850.2170.2590.2650.1980.1290.1160.1180.2250.2590.20.2050.004
Total Other Income Expenses Net 152.06259.61739.012149.337-116.5581.8435.11224.59523.54842.00921.53119.919-4.668-0.132-0.159-2.730.723-0.005
Income Before Tax 1,575.6741,147.985732.88558.637219.611336.307339.208331.519288.581201.978111.641111.33889.40763.36853.61147.87861.3510.036
Income Before Tax Ratio 0.2770.2220.20.2570.1130.1860.2420.2590.2650.1980.1290.1160.1120.2240.2580.1890.2070.004
Income Tax Expense 365.423252.44163.983113.07576.51392.98299.54392.53891.44456.02833.48130.2224.81420.82318.62417.87822.7630.01
Net Income 1,198.088883.158551.744425.875130.761225.243226.956206.347170.405129.14865.01170.36460.04142.54534.9873038.5870.026
Net Income Ratio 0.2110.1710.150.1960.0670.1240.1620.1610.1570.1270.0750.0730.0750.1510.1690.1190.130.003
EPS 10.827.974.983.841.172.022.042.321.521.150.580.630.540.580.50.430.570.001
EPS Diluted 10.827.974.983.841.172.022.042.321.521.150.580.630.540.580.50.430.560.001
EBITDA 1,483.8151,198.99729.828437.045358.963348.4305.128312.725286.255177.62585.25982.26896.94964.80655.03751.56561.4990.041
EBITDA Ratio 0.2610.2320.1990.2010.1840.1930.2180.2440.2630.1740.0980.0860.1210.2290.2650.2040.2080.004